High resolution two-dimensional electrophoresis (2DE) and silver staining have provided a technology capable of mapping large numbers of proteins from tissues and body fluids. Further identification of individual proteins that have been visualized by 2DE includes their characterization by immunodetection methods and by obtaining amino acid sequences from which antibody and synthetic oligonucleotide probes can be synthesized. As many as 3,500 individual proteins may be observed on a single electrophoretogram. This capacity to observe gene products permits the scanning of as many as 3.5 megabases of the protein coding regions of the genome for mutational events on each gel, and may also provide evidence concerning abnormal rates of protein synthesis or degradation, posttranslational modifications, and the presence of gene products of exogenous origin. The application of this technology has revealed a pair of abnormal cerebrospinal fluid (CSF) proteins (40KD) in one-third of schizophrenic patients screened. These abnormal proteins have never been observed in CSF from normal controls. However, they have been detected in some diseases of the central nervous system that may be of viral origin. Structural studies on these proteins should provide evidence of their origin, while ongoing studies of brain proteins may provide additional clues about this disease.
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The introduction of twodimensional high-resolution electrophoresis (2DE) by OTarrell in 1975 permitted an order-ofmagnitude increase in the resolution of proteins. This advance in separation technology, coupled with the high sensitivity of silver stains Switzer et al. 1979) , permitted the visualization and determination of the charge and mass of hundreds, and in some cases thousands, of proteins from body fluids and tissues.
Proteins that are separated by 2DE are mapped by their charge and mass, and then must be further characterized. Study of their origin and function can best be achieved by confirmation of identity by comigration with a purified protein on a 2DE-gel, recognition by a specific antibody on a western-blot of a 2DE gel, or by obtaining a partial amino acid sequence of the protein (Aebersold et al. 1987) . The origin and function of the protein may then be directly obtained by referencing the protein and nucleic acid sequence data banks. These data banks may also give access to the role of the specific protein in the metabolic network. Alternatively, if the protein contains a novel sequence, then such a sequence provides an initial focus for further studies.
Two major strategies have been followed in using these technologies to search for diagnostic markers and clues about the underlying pathophysiology of schizophrenia. One strategy is to search for disease-associated proteins and protein changes in tissues and body fluids (the disease-association strategy). The other strategy uses genetically variant proteins, polymorphic proteins, to establish genetic linkage with a disease locus in families and sib-pairs (the polymorphism strategy).
Brain Protein Maps
In one of the first reported 2DE studies of proteins in the central nervous system (CNS), Comings (1979) used a combination of the two strategies to analyze proteins extracted from the caudate and putamen regions of 602 brains. These regions were chosen because they are major sites of dopaminergic neurons, which are believed to be involved in schizophrenia A polymorphic protein, Pc 1 Duarte, demonstrated significant correlations with depressive diseases and multiple sclerosis. However, no correlations were observed between the Pc 1 Duarte protein variants or any of the other proteins examined and schizophrenia. In a second study of brain proteins by Comings (1982) , a larger number of proteins were examined' 176 major brain proteins in 145 cortical and cerebellar samples Although no protein alterations were found to be associated with schizophrenia, a mutant form of a protein was found to be associated with Joseph's disease.
Surveys for human diseaseassociated brain protein changes are hampered by a lack of knowledge of normal brain proteins and their variations during normal physiological and pharmacological events In this regard, studies of CNS proteins in nonhuman mammalian models are likely to provide control data that cannot be obtained in human studies Although 2DE has been used to study protein alterations in specific regions of the brain following experimental manipulations (Wagner et al. 1979 , Deutsch et al 1980 , there are few studies of proteins in regions of the normal mammalian brain Heydorn et al. (1983) performed a limited quantitative analysis of the male rat brain They examined 91 proteins from 25 different brain regions and found that although the majority of proteins selected for quantitative analysis varied less than fourfold in concentration between the neuroanatomical sites, 10 percent of the proteins varied widely, with concentrations ranging more than tenfold between the regions with the highest and lowest amounts The number of proteins examined in their study was limited by the lack of fully automated gel matching and quantitation facilities.
Future studies in animal models should investigate many more proteins on each gel and determine protein alterations during development, maturation, and aging of the mammalian CNS. Such background knowledge of age-related protein alterations would be particularly helpful in human diseases with characteristic ages of onset, such as Alzheimer's disease in the senior years or schizophrenia at puberty. Similarly, CNS proteins that are affected by drug administration and physiological events, such as stress, can be identified in animal models and may offer clues concerning human pathophysiology Proteins affected by antischizophrenic or neuroleptic drugs should be examined very closely in human brain studies Human brain studies must address additional problems such as the terminal physiological state of the patient and the effects on brain proteins of drugs administered to the patient before death. The interpretation of these protein patterns will depend on knowledge gained in the nonhuman mammalian brain studies, such as those described above. Time-dependent protein alterations that may occur after death may cause difficulties Such protein changes should also be studied in nonhuman mammalian models; in humans, they may be alleviated in part by rapid postmortem protocols
Spinal Fluid Protein Maps
Examination of cerebrospmal fluid (CSF) proteins offers the possibility of detecting abnormal gene products associated with CNS diseases Although most of the proteins in the CSF are believed to be filtration products of the blood, some are derived from brain and spinal cord. Acetylcholinesterase activity in the CSF has been shown to increase after treatment with chlorpromazine (Greenfield et al 1978) , while the enzyme dopamine-/3-hydroxylase has been found to vary with central noradrenergic activity (Lerner et al. 1979) .
High-resolution 2DE and silver staining has permitted the visualization of more than 300 spinal fluid proteins of which 26 have been identified . Some of them appear to be CSF-specific (Mernl et al. 1981 ) Harrington and Merril (1984; , in extensive studies of CSF from normal controls and individuals with various CNS diseases, demonstrated a new 25KD protein in Parkinson's disease In addition, they found four other diseaseassociated proteins in CreutzfeldtJakob disease, herpes simplex encephalitis, Guillain-Barre syndrome, multiple sclerosis, Parkinson's disease, and schizophrenia (Harrington et al. 1985 (Harrington et al. , 1986 ) Two of these CSF proteins (with molecular weights of 29KD and 26KD, and isoelectric points of 5 1 and 5 2, VOL 14. NO. Z. 1968 respectively) were found in 100 percent of the patients with Creutzfeldt-Jakob disease, and 50 percent of the patients with herpes simplex encephalitis. The other two proteins (both have molecular weights of 40KD and isoelectric points of 5.7 and 5.9) have been observed in Creutzfeldt-Jakob disease (67 percent of the patients), herpes simplex encephalitis (90 percent), Guillain-Barre syndrome (100 percent), multiple sclerosis (13 percent), Parkinson's disease (12 percent), and schizophrenia (32 percent).
The new proteins observed in the CSF of the schizophrenic patients (figure 1) are believed to have originated within the CNS, as they could not be detected in tenfold concentrates of CSF from normal volunteers or in the patients' serum. It is unlikely that the appearance of these proteins is drug-related, as there was no common drug used in the treatment of the patients who displayed the abnormal proteins compared to patients who did not have abnormal CSF proteins (Harrington et al. 1985) . Furthermore, it may be of some importance that all of the nonschizophrenic patients who displayed the abnormal 40KD CSF proteins had diseases of suspected viral origin. The common etiology of these disease-associated proteins is not known; however, the 32 percent of schizophrenic patients displaying these abnormal CSF proteins may belong to a subclass with a viral component in their disease process.
Polymorphisms
In schizophrenia, which appears to have a genetic component, it is difficult to conduct studies concerning the genetic variations of brain proteins because the investigator is generally limited to autopsy material. Furthermore, time constraints make it difficult to perform multigenerational family studies. Peripheral tissue and body fluid proteins, however, are available for genetic linkage studies. While neural tissue would be ideal for the study of a brain disorder, CNS specificity is not a prerequisite for neuronal involvement in genetic diseases involving the CNS. Mutations in genes that are expressed in most somatic tissues, such as the galactose-transferase gene in galactosemia or the hypoxanthine-guanine-phosphoribosyl transferase gene in Lesch-Nyhan syndrome, may result in mental retardation or self-mutilation, respectively.
High-resolution 2DE proteins offer a molecular genetic method in addition to the nucleic acid methods for genetic linkage studies. In a survey of 186 human lymphocyte proteins, 19 independent polymorphic protein systems were observed . Each of these polymorphic systems consisted of two to three allelic charge variants that displayed mendelian inheritance with codominant expression in heterozygotes and strict genotypic concordance in homyzygotic twins . About 10 percent of the cellular protein loci displayed polymorphic variations . Rosenblum et al. (1983 Rosenblum et al. ( , 1984 estimated the average protein charge heterozygosity of human serum and erythrocyte loci, detected by 2DE, to be 6.2 percent and 3.1 percent, respectively. were able to screen 27 independent polymorphic loci in two large families by analyzing serum, erythrocyte, and fibroblast proteins.
Protein gel electrophoresis __ provides a more efficient method of screening polymorphisms in terms of the number of potential markers that may be screened per gel as compared with the southern blot restriction fragment length polymorphism (RFLP) detection methods. Southern blot RFLP are generally used to screen a single polymorphic system at a time, whereas 19 such systems may be screened while analyzing 186 loci in a 2DE pattern. With improvements in automated methods of analyzing the complex 2DE patterns, it should be possible to score more protein loci. It is not uncommon now to visualize as many as 1,000 protein loci in a single gel. If the ratio of polymorphic loci approximates that observed in the analysis of the 186 aforementioned lymphocyte protein loci, it may be possible to score as many as 102 polymorphic loci in a single gel. In a survey of 40 polymorphic protein markers, 40 percent of these were moderately informative for linkage analysis according to the definition of Botstein et al. (1980) . Such additional linkage markers available through 2DE techniques should provide a valuable adjunct to RFLP linkage studies.
Conclusions
Our understanding of the origin and function of abnormal CSF proteins (e.g., the one found in onethird of schizophrenic patients) will be greatly assisted once these proteins have been isolated in sufficient quantity to have their primary structures determined. Knowledge of the amino acid sequences of these proteins will permit the production of antibodies and DNA probes to test for their endogenous or exogenous origin. The development of such probes may also lead to new diagnostic markers and a further understanding of the molecular neuropathology of the diseases that display these abnormal proteins
The analysis of protein patterns in family and sib-pair studies may serve both in providing polymorphic loci for linkage analysis and in finding quantitative variations in proteins that would be difficult to predict from the genomic information at this time. 
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Twenty microhters of CSF were applied to each gel The top pattern (labeled IEF) illustrates the separation of the proteins by their charge, using the method of isoelectric focusing The pattern on the right side of the figure (labeled S D S PAGE) illustrates the separation of the proteins by their mass The central two-dimensional gel illustrates the increased resolution of the combined separation effect of the 2 independent parameters, charge and mass The 2 arrowed proteins are the 40KD abnormal CSF proteins found in one-third of the schizophrenic patients studied, as described in the text VOL 14. NO. 2.1388
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Many schemes have been introduced using molecular biology to find abnormal genes in schizophrenia, such as the use of exhaustive subtraction hybridization between mRNAs and DNA libraries. The quest to establish genetic linkage with DNA or polymorphic protein markers has already proved to be of value in determining the genetic location of other disease loci. Furthermore, the establishment of brain protein maps offers the possibility of a better understanding of the molecular pathophysiology of schizophrenia and the opportunity to develop more rational therapy. Such technological undertakings will require a major research commitment for 2DE, protein sequencing, and data base management.
